Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthew R Strickland

Showing results (1-10 of 27) with videos related to

Pageof 3
Sort By:
Annals of Translational Medicine|January 13, 2021
Devil in the detail: MET overexpression fails as surrogate marker for <i>MET</i> exon 14 splice site mutations in NSCLCMatthew R Strickland, Pasi A Jänne
Med (New York, N.Y.)|October 12, 2024
Dual HER2 inhibition: Is two better than one?Matthew R Strickland, Samuel J Klempner
Journal of Gastrointestinal Cancer|February 14, 2024
Role of Preoperative Radiation Therapy for Resectable Gastric CancerGrace Lee, Matthew R Strickland, Jennifer Y Wo
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 5, 2026
Reply to: Quality of Chemoradiotherapy in Esophageal Adenocarcinoma MattersMatthew R Strickland, Samuel J Klempner, Theodore S Hong
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 7, 2025
Apples, Oranges, and ESOPEC Recurrence PatternsMatthew R Strickland, Theodore S Hong, Samuel J Klempner
Cancer Discovery|April 8, 2022
Tumor Immune Microenvironment of Brain Metastases: Toward Unlocking Antitumor ImmunityMatthew R Strickland, Christopher Alvarez-Breckenridge, Justin F Gainor, et al.
Healthcare (Basel, Switzerland)|December 8, 2023
Recent Advances in the Management of Anal CancerLaxmi Upadhyay, Michelle Hartzell, Aparna R Parikh, et al.
Journal of Gastrointestinal Oncology|January 10, 2024
Development and validation of a nomogram to predict pathological complete response in patients with locally advanced gastric adenocarcinoma treated with neoadjuvant chemotherapy in combination with PD-1 antibodiesLiang Li, Guanglong Chen, Emerson Y Chen, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|March 19, 2024
Gastroesophageal Adenocarcinomas With Defective Mismatch Repair: Current Knowledge and Clinical ManagementMatthew R Strickland, Eric M Lander, Michael K Gibson, et al.
Pharmaceutics|December 23, 2023
DNA Damage by Radiopharmaceuticals and Mechanisms of Cellular RepairYousef Khazaei Monfared, Pedram Heidari, Samuel J Klempner, et al.
Pageof 3

Showing results (1-10 of 27) with videos related to

Sort By:
Pageof 3
Annals of Translational Medicine|January 13, 2021
Devil in the detail: MET overexpression fails as surrogate marker for <i>MET</i> exon 14 splice site mutations in NSCLCMatthew R Strickland, Pasi A Jänne
Med (New York, N.Y.)|October 12, 2024
Dual HER2 inhibition: Is two better than one?Matthew R Strickland, Samuel J Klempner
Journal of Gastrointestinal Cancer|February 14, 2024
Role of Preoperative Radiation Therapy for Resectable Gastric CancerGrace Lee, Matthew R Strickland, Jennifer Y Wo
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 5, 2026
Reply to: Quality of Chemoradiotherapy in Esophageal Adenocarcinoma MattersMatthew R Strickland, Samuel J Klempner, Theodore S Hong
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 7, 2025
Apples, Oranges, and ESOPEC Recurrence PatternsMatthew R Strickland, Theodore S Hong, Samuel J Klempner
Cancer Discovery|April 8, 2022
Tumor Immune Microenvironment of Brain Metastases: Toward Unlocking Antitumor ImmunityMatthew R Strickland, Christopher Alvarez-Breckenridge, Justin F Gainor, et al.
Healthcare (Basel, Switzerland)|December 8, 2023
Recent Advances in the Management of Anal CancerLaxmi Upadhyay, Michelle Hartzell, Aparna R Parikh, et al.
Journal of Gastrointestinal Oncology|January 10, 2024
Development and validation of a nomogram to predict pathological complete response in patients with locally advanced gastric adenocarcinoma treated with neoadjuvant chemotherapy in combination with PD-1 antibodiesLiang Li, Guanglong Chen, Emerson Y Chen, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|March 19, 2024
Gastroesophageal Adenocarcinomas With Defective Mismatch Repair: Current Knowledge and Clinical ManagementMatthew R Strickland, Eric M Lander, Michael K Gibson, et al.
Pharmaceutics|December 23, 2023
DNA Damage by Radiopharmaceuticals and Mechanisms of Cellular RepairYousef Khazaei Monfared, Pedram Heidari, Samuel J Klempner, et al.
Pageof 3